Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Nath Bio-Genes (India) Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199231-03-2015
31-03-2015
Outcome of Board Meeting
Nath Bio-Genes (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 30, 2015, and Mrs. Sweta Garodia and Mr. Shrirang Agrawal are appointed as Director of the Company.30-03-2015
Limited Review for Dec 31, 2014
Nath Bio-Genes (India) Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended December 31, 2014.06-02-2015
Financial Results for Dec 31, 2014 (Standalone)
Nath Bio-Genes (India) Ltd has informed BSE about the Standalone Financial Results for the period ended December 31, 2014.02-02-2015
Shareholding Pattern For December 31, 2014
Nath Bio-Genes (India) Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014.19-01-2015
Limited Review for Sept 30, 2014
Nath Bio-Genes (India) Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended September 30, 2014.17-11-2014
Statement of Assets & Liabilities for Sep 30, 2014
Nath Bio-Genes (India) Ltd has submitted to BSE a copy of Statement of Assets & Liabilities as on September 30, 2014.17-11-2014
Outcome of Board Meeting
Nath Bio-Genes (India) Ltd has informed BSE that at the meeting of the Board of Directors of the Company held on October 30, 2014, Mrs. Sweta Garodia is appointed as Director of the Company.04-11-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Nath Bio-Genes (India) Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199202-11-2014
Financial Results for Sept 30, 2014 (Standalone)
Nath Bio-Genes (India) Ltd has informed BSE about the Standalone Financial Results for the period ended September 30, 2014.30-10-2014